^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
RNAscope™ ISH Probe High Risk HPV

Company:
Bio-Techne
Type:
CE Marked
Related tests:

Details

Evidence
RNAscope in situ hybridization (ISH) gives anatomic pathologists a direct method for detection of active HPV through interrogation of E6/E7 viral oncogene mRNA, targets that provide unequivocal evidence of HPV in contrast to p16, a surrogate marker, which is upregulated by HPV as well as other non-HPV pathways
Cancer:
Head and Neck Cancer, Oropharyngeal Cancer
Method:
In situ hybridization (ISH)
Approvals
Date
Cancer
Gene
Drug
By
07/06/22
CE
Confirmatory trial(s)